Lee SH - Search Results

1

Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study.

Kim T, Jang TW, Choi CM, Kim MH, Lee SY, Chang YS, Lee KY, Kim SJ, Yang SH, Ryu JS, Lee JE, Lee SY, Park CK, Lee SH, Jang SH, Yoon SH, Oh HJ. Kim T, et al. Among authors: lee sh, lee sy, lee je, lee ky. Cancer Res Treat. 2023 Oct;55(4):1152-1170. doi: 10.4143/crt.2023.493. Epub 2023 May 19. Cancer Res Treat. 2023. PMID: 37218139 Free PMC article.

2

Tumor clonal status predicts clinical outcomes of lung adenocarcinoma with EGFR-TKI sensitizing mutation.

Kim EY, Lee SH, Kim A, Kim T, Chang YS. Kim EY, et al. Among authors: lee sh. J Cancer. 2019 Aug 29;10(22):5549-5556. doi: 10.7150/jca.32897. eCollection 2019. J Cancer. 2019. PMID: 31632498 Free PMC article.

3

Presence of mEGFR ctDNA predicts a poor clinical outcome in lung adenocarcinoma.

Kim T, Kim EY, Lee SH, Kwon DS, Kim A, Chang YS. Kim T, et al. Among authors: lee sh. Thorac Cancer. 2019 Dec;10(12):2267-2273. doi: 10.1111/1759-7714.13219. Epub 2019 Oct 24. Thorac Cancer. 2019. PMID: 31647198 Free PMC article.

4

Recent advances in diagnostic technologies in lung cancer.

Park HJ, Lee SH, Chang YS. Park HJ, et al. Among authors: lee sh. Korean J Intern Med. 2020 Mar;35(2):257-268. doi: 10.3904/kjim.2020.030. Epub 2020 Feb 28. Korean J Intern Med. 2020. PMID: 32131569 Free PMC article. Review.

5

Compared to plasma, bronchial washing fluid shows higher diagnostic yields for detecting EGFR-TKI sensitizing mutations by ddPCR in lung cancer.

Lee SH, Kim EY, Kim T, Chang YS. Lee SH, et al. Respir Res. 2020 Jun 9;21(1):142. doi: 10.1186/s12931-020-01408-x. Respir Res. 2020. PMID: 32517757 Free PMC article.

6

Clinical implication and usefulness of de novo EGFR T790M mutation in lung adenocarcinoma with EGFR-tyrosine kinase inhibitor sensitizing mutation.

Lee SH, Kim EY, Kim A, Chang YS. Lee SH, et al. Cancer Biol Ther. 2020 Aug 2;21(8):741-748. doi: 10.1080/15384047.2020.1776579. Epub 2020 Jun 16. Cancer Biol Ther. 2020. PMID: 32543264 Free PMC article.

7

Increased number of subclones in lung squamous cell carcinoma elicits overexpression of immune related genes.

Song MJ, Lee SH, Kim EY, Chang YS. Song MJ, et al. Among authors: lee sh. Transl Lung Cancer Res. 2020 Jun;9(3):659-669. doi: 10.21037/tlcr-19-589. Transl Lung Cancer Res. 2020. PMID: 32676328 Free PMC article.

8

Prediction model for hyperprogressive disease in non-small cell lung cancer treated with immune checkpoint inhibitors.

Choi YJ, Kim T, Kim EY, Lee SH, Kwon DS, Chang YS. Choi YJ, et al. Among authors: lee sh. Thorac Cancer. 2020 Oct;11(10):2793-2803. doi: 10.1111/1759-7714.13594. Epub 2020 Aug 11. Thorac Cancer. 2020. PMID: 32779394 Free PMC article.

9

Clinical impact of rebiopsy among patients with epidermal growth factor receptor-mutant lung adenocarcinoma in a real-world clinical setting.

Nam Y, Kim HC, Kim YC, Jang SH, Lee KY, Lee SY, Lee SH, Lee SY, Yoon SH, Ryu JS, Jang TW, Chang YS, Kim SJ, Park CK, Lee JE, Jung CY, Choi CM. Nam Y, et al. Among authors: lee sh, lee sy, lee je, lee ky. Thorac Cancer. 2021 Mar;12(6):890-898. doi: 10.1111/1759-7714.13857. Epub 2021 Feb 2. Thorac Cancer. 2021. PMID: 33529490 Free PMC article.

10

The relationship between the severity of pulmonary fibrosis and the lung cancer stage.

Jang HJ, Park MS, Kim YS, Chang J, Lee JH, Lee CT, Lee SH, Yoon HI. Jang HJ, et al. Among authors: lee sh, lee jh, lee ct. J Cancer. 2021 Mar 14;12(10):2807-2814. doi: 10.7150/jca.51445. eCollection 2021. J Cancer. 2021. PMID: 33854581 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23,551 results

Search Page